MAPT and Alzheimer disease: AD is characterized by progressive cognitive decline, primarily driven by the accumulation of Aβ in senile plaques and hyperphosphorylated tau in neurofibrillary tangles, leading to synaptic dysfunction and neurodegeneration [24].